ciprofloxacin has been researched along with Extensively Drug-Resistant Tuberculosis in 4 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Extensively Drug-Resistant Tuberculosis: Tuberculosis resistant to ISONIAZID and RIFAMPIN and at least three of the six main classes of second-line drugs (AMINOGLYCOSIDES; polypeptide agents; FLUOROQUINOLONES; THIOAMIDES; CYCLOSERINE; and PARA-AMINOSALICYLIC ACID) as defined by the CDC.
| Excerpt | Relevance | Reference |
|---|---|---|
| "All ciprofloxacin DST results were susceptible by both methods." | 1.56 | MDR/XDR-TB Colour Test for drug susceptibility testing of Mycobacterium tuberculosis, Northwest Ethiopia. ( Balada-Llasat, JM; Evans, CA; Gelaw, B; Kelley, HV; Shibabaw, A; Tesfaye, E; Tessema, B; Torrelles, JB; Wang, SH, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shibabaw, A | 1 |
| Gelaw, B | 1 |
| Kelley, HV | 1 |
| Tesfaye, E | 1 |
| Balada-Llasat, JM | 1 |
| Evans, CA | 2 |
| Torrelles, JB | 1 |
| Wang, SH | 1 |
| Tessema, B | 1 |
| Sharma, A | 1 |
| De Rosa, M | 1 |
| Singla, N | 1 |
| Singh, G | 1 |
| Barnwal, RP | 1 |
| Pandey, A | 1 |
| Disratthakit, A | 1 |
| Prammananan, T | 1 |
| Tribuddharat, C | 1 |
| Thaipisuttikul, I | 1 |
| Doi, N | 1 |
| Leechawengwongs, M | 1 |
| Chaiprasert, A | 1 |
| Toit, K | 1 |
| Mitchell, S | 1 |
| Balabanova, Y | 1 |
| Kummik, T | 1 |
| Nikolayevskyy, V | 1 |
| Drobniewski, F | 1 |
4 other studies available for ciprofloxacin and Extensively Drug-Resistant Tuberculosis
| Article | Year |
|---|---|
MDR/XDR-TB Colour Test for drug susceptibility testing of Mycobacterium tuberculosis, Northwest Ethiopia.
Topics: Adolescent; Adult; Antitubercular Agents; Ciprofloxacin; Culture Media; Ethiopia; Extensively Drug-R | 2020 |
Tuberculosis: An Overview of the Immunogenic Response, Disease Progression, and Medicinal Chemistry Efforts in the Last Decade toward the Development of Potential Drugs for Extensively Drug-Resistant Tuberculosis Strains.
Topics: Antitubercular Agents; Ciprofloxacin; Disease Progression; Drug Carriers; Drug Evaluation, Preclinic | 2021 |
Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
Topics: Aminopyridines; Antitubercular Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Extens | 2016 |
The Colour Test for drug susceptibility testing of Mycobacterium tuberculosis strains.
Topics: Antitubercular Agents; Ciprofloxacin; Color; Drug Resistance, Multiple, Bacterial; Estonia; Extensiv | 2012 |